Heavy-chain CDR3-engineered B cells facilitate <i>in vivo</i> evaluation of HIV-1 vaccine candidates
Wenhui He(Scripps Research Institute), Michael Farzan(Scripps Research Institute)
Cited by 0
Related Papers
The broad-spectrum antiviral functions of IFIT and IFITM proteins
|Nature reviews. Immunology|2012|855
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
|PLoS Pathogens|2011|629
Heavy-chain CDR3-engineered B cells facilitate in vivo evaluation of HIV-1 vaccine candidates
|Immunity|2023|16
In vivo affinity maturation of the CD4 domains of an HIV-1-entry inhibitor
|Nature Biomedical Engineering|2024|14
<i>In vivo</i> affinity maturation of the HIV-1 Env-binding domain of CD4
|bioRxiv (Cold Spring Harbor Laboratory)|2024|1